{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_target_monoamine_oxidase",
          "type": "Target",
          "label": "Monoamine Oxidase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_neurotransmitter_regulation",
          "type": "Pathway",
          "label": "Neurotransmitter Regulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease_neurotransmitter_disorder",
          "type": "Disease",
          "label": "Neurotransmitter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_phenelzine",
          "type": "Phenotype",
          "label": "Effect of Phenelzine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_tranylcypromine",
          "type": "Phenotype",
          "label": "Effect of Tranylcypromine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_isocarboxazid",
          "type": "Phenotype",
          "label": "Effect of Isocarboxazid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_selegiline",
          "type": "Phenotype",
          "label": "Effect of Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_bupropion",
          "type": "Phenotype",
          "label": "Effect of Bupropion",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_fluoxetine",
          "type": "Phenotype",
          "label": "Effect of Fluoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_trazodone",
          "type": "Phenotype",
          "label": "Effect of Trazodone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_dextroamphetamine",
          "type": "Phenotype",
          "label": "Effect of Dextroamphetamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_venlafaxine",
          "type": "Phenotype",
          "label": "Effect of Venlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_desvenlafaxine",
          "type": "Phenotype",
          "label": "Effect of Desvenlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_methylphenidate",
          "type": "Phenotype",
          "label": "Effect of Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_atomoxetine",
          "type": "Phenotype",
          "label": "Effect of Atomoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Phenelzine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_phenelzine",
          "type": "Drug",
          "label": "Phenelzine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Tranylcypromine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_tranylcypromine",
          "type": "Drug",
          "label": "Tranylcypromine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Isocarboxazid",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_isocarboxazid",
          "type": "Drug",
          "label": "Isocarboxazid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Selegiline",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_selegiline",
          "type": "Drug",
          "label": "Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Bupropion",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bupropion",
          "type": "Drug",
          "label": "Bupropion",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_fluoxetine",
          "type": "Drug",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Trazodone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_trazodone",
          "type": "Drug",
          "label": "Trazodone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Dextroamphetamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_dextroamphetamine",
          "type": "Drug",
          "label": "Dextroamphetamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_venlafaxine",
          "type": "Drug",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Desvenlafaxine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_desvenlafaxine",
          "type": "Drug",
          "label": "Desvenlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methylphenidate",
          "type": "Drug",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Atomoxetine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_atomoxetine",
          "type": "Drug",
          "label": "Atomoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_phenelzine",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Phenelzine as a monoamine oxidase inhibitor."
        },
        {
          "source": "drug_tranylcypromine",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Tranylcypromine acts as a monoamine oxidase inhibitor."
        },
        {
          "source": "drug_isocarboxazid",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Isocarboxazid functions as an MAOI."
        },
        {
          "source": "drug_selegiline",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Selegiline is used as a selective MAOI."
        },
        {
          "source": "drug_bupropion",
          "target": "n_target_monoamine_oxidase",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Bupropion affects dopamine and norepinephrine."
        },
        {
          "source": "drug_fluoxetine",
          "target": "n_target_monoamine_oxidase",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Fluoxetine primarily affects serotonin."
        },
        {
          "source": "drug_trazodone",
          "target": "n_target_monoamine_oxidase",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Trazodone acts on serotonin pathways."
        },
        {
          "source": "n_target_monoamine_oxidase",
          "target": "n_pathway_neurotransmitter_regulation",
          "relation": "involved_in",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "Key role in neurotransmitter regulation."
        },
        {
          "source": "n_pathway_neurotransmitter_regulation",
          "target": "n_disease_neurotransmitter_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Regulation issues lead to neurotransmitter disorders."
        },
        {
          "source": "drug_phenelzine",
          "target": "n_ph_phenelzine",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Positive clinical effects linked to its mechanism."
        },
        {
          "source": "drug_tranylcypromine",
          "target": "n_ph_tranylcypromine",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Supports favorable outcomes in similar indications."
        },
        {
          "source": "drug_isocarboxazid",
          "target": "n_ph_isocarboxazid",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Positive effects noted in treatment studies."
        },
        {
          "source": "drug_selegiline",
          "target": "n_ph_selegiline",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Commonly shows effectiveness in related conditions."
        },
        {
          "source": "drug_bupropion",
          "target": "n_ph_bupropion",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Known for its effects on depression."
        },
        {
          "source": "drug_fluoxetine",
          "target": "n_ph_fluoxetine",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Standard treatment for depression."
        },
        {
          "source": "drug_trazodone",
          "target": "n_ph_trazodone",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Often prescribed for depressive disorders."
        },
        {
          "source": "drug_dextroamphetamine",
          "target": "n_ph_dextroamphetamine",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Used in ADHD with effects on neurotransmitters."
        },
        {
          "source": "drug_venlafaxine",
          "target": "n_ph_venlafaxine",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Dual-action antidepressant affects neurotransmitters."
        },
        {
          "source": "drug_desvenlafaxine",
          "target": "n_ph_desvenlafaxine",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Effective in similar patient profiles."
        },
        {
          "source": "drug_methylphenidate",
          "target": "n_ph_methylphenidate",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Impacts attention disorders related to neurotransmission."
        },
        {
          "source": "drug_atomoxetine",
          "target": "n_ph_atomoxetine",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Non-stimulant treatment for ADHD linked to dopamine regulation."
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.83,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Phenelzine inhibits monoamine oxidase, involved in neurotransmitter regulation."
            ],
            "safety_risk": [
              "Potential dietary interaction risks are minimal."
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.81,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Tranylcypromine acts as a monoamine oxidase inhibitor, influencing neurotransmitter levels."
            ],
            "safety_risk": [
              "Slightly less problematic regarding dietary restrictions than other MAOIs."
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.83,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Isocarboxazid inhibits monoamine oxidase, impacting neurotransmitter homeostasis."
            ],
            "safety_risk": [
              "Similar safety profile as other MAOIs with dietary interaction warnings."
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.8,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.7,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Selegiline functions as a selective MAOI affecting neurotransmitter pathways."
            ],
            "safety_risk": [
              "Dietary restriction safety issues are manageable."
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Bupropion modifies neurotransmitters differently than MAOIs."
            ],
            "safety_risk": [
              "Minimal dietary interaction risks."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.74,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Fluoxetine's primary effect on serotonin may avoid MAO interactions."
            ],
            "safety_risk": [
              "Known to be safer compared to traditional MAOIs."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.72,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Trazodone's serotonin effects differ from MAOIs."
            ],
            "safety_risk": [
              "Use is cautionary but not primarily contraindicated."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.71,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Dextroamphetamine impacts dopamine and norepinephrine with different mechanisms."
            ],
            "safety_risk": [
              "Cardiovascular effects exist but MAO interactions are less significant."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.69,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Venlafaxine's unique dual action does not engage with MAOI considerations."
            ],
            "safety_risk": [
              "Considered low risk relative to MAOIs."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Desvenlafaxine follows mechanisms similar to venlafaxine, avoiding MAO interactions."
            ],
            "safety_risk": [
              "Dietary interactions are not a key concern."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Methylphenidate operates on distinct pathways related to attention."
            ],
            "safety_risk": [
              "Potential cardiovascular effects are present, but MAO interactions are minimal."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.64,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Atomoxetine is a non-stimulant ADHD treatment with a different mechanism."
            ],
            "safety_risk": [
              "Not directly contraindicated relative to MAOIs."
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Phenelzine's dietary restrictions",
            "expectation": "Confirm the minimal interaction risks present.",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Examine any possible contraindications specific to food interactions.",
          "Evaluate the potential impact of MAOI contraindications on treatment effectiveness."
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Tranylcypromine's dietary restrictions",
            "expectation": "Assess the degree of dietary interaction risks.",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Discuss specific cases where dietary interactions might arise.",
          "Clarify the implications of using Tranylcypromine in conjunction with certain foods."
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Isocarboxazid's dietary restrictions",
            "expectation": "Determine if dietary interactions represent a significant risk.",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Identify foods that may cause reactions with Isocarboxazid.",
          "Assess the practicality of implementing the dietary restrictions."
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Selegiline's dietary restrictions",
            "expectation": "Explore what dietary precautions are recommended.",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Debate the realities of experiencing side effects when dietary restrictions aren't followed.",
          "Clarify if Selegiline's mechanism alters the risk of these interactions."
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": true,
      "reason": "Current hypotheses face potential contraindications related to dietary interactions, necessitating new insights into safer alternatives or mechanisms.",
      "n": 4
    }
  }
}